SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SUNPHARM Pharmaceuticals (SUNP) -- Ignore unavailable to you. Want to Upgrade?

To: F. Jay Abella, III who wrote (7)11/24/1997 5:48:00 PM
From: Bradpalm1  Respond to of 52
 
Jay,

This company sounds interesting but I question the nature and long-term safety of a compound with anti-secretory, anti-motility AND anti-proliferative properties. Do you have any other information or references pertaining to the actual pharmacological actions of these 'naturally-occurring polyamine analogues'?

Bradpalm1



To: F. Jay Abella, III who wrote (7)11/24/1997 9:35:00 PM
From: Tim K  Read Replies (1) | Respond to of 52
 
I started watching this one recently. Impressive package from the company. I like the array of products, low burn rate, apparently good management, and low float. Warner-Lambert (Parke-Davis) backing indicates they envision a high commercial potential.

The price has escalated in the past two months. Do you see it dropping near term for any reason?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News